From non-uptake during early adolescence to acceptance during a catch-up campaign: a qualitative study of changing HPV vaccination decisions across two life stages among young women in Amsterdam, the Netherlands

Background: Human Papillomavirus (HPV) vaccination effectively prevents HPV-related disease, but its population-level impact depends on sufficient coverage. In 2023-2024, the Netherlands offered free HPV vaccination to individuals aged 19-27 years through a national catch-up campaign. For women, this was a second opportunity, as they had been offered vaccination at ages 9-13 through the National Immunisation Programme (NIP). Back then, uptake was relatively low (46-57% in these birth cohorts), but uptake increased to 55-63% following the catch-up vaccination. This campaign provided an apt opportunity to explore the factors underlying previous and current HPV vaccination decisions among the same women across two life stages. Methods: Between May 2023 and May 2024, 16 semi-structured interviews were conducted in Amsterdam with women who accepted HPV vaccination during the catch-up after non-uptake during early adolescence. Interviews explored factors influencing non-uptake and later acceptance, guided by the Health Belief Model and additional sociocultural constructs. Data were analysed using thematic analysis with open and theory-guided coding in MAXQDA. Results: Non-uptake during early adolescence was primarily shaped by parental decision-making, cultural and religious norms, fear of side effects, low perceived susceptibility to HPV and limited self-efficacy. Acceptance in young adulthood was driven by greater autonomy, higher perceived susceptibility, increased trust in accumulated vaccine evidence and accessible vaccination infrastructure. Peer influence replaced parental influence as the dominant social factor. Conclusion: HPV vaccine decision-making is a dynamic process rather than fixed. Permanent catch-up HPV vaccination opportunities would enable young adults to make autonomous vaccination decisions as their circumstances change.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-10-27
DOI
https://doi.org/10.64898/2026.10.27.26366415
Primary Topic
Cervical Cancer and HPV Research
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

From non-uptake during early adolescence to acceptance during a catch-up campaign: a qualitative study of changing HPV vaccination decisions across two life stages among young women in Amsterdam, the Netherlands

Sarah van Veelen, Maarten F. Schim van der Loeff, Catharina J. Alberts, Udi Davidovich et al.
2 links
medRxiv
Cervical Cancer and HPV Research
preprint

From non-uptake during early adolescence to acceptance during a catch-up campaign: a qualitative study of changing HPV vaccination decisions across two life stages among young women in Amsterdam, the Netherlands

Sarah van Veelen, Maarten F. Schim van der Loeff, Catharina J. Alberts, Udi Davidovich, Eline S. Wijstma, Gertrude Nsorma Nyaaba, Johannes A. Bogaards, Laura Denis, Anouk Wisse, Puck Ellemijn Kahlmann
preprint en

Abstract

Background: Human Papillomavirus (HPV) vaccination effectively prevents HPV-related disease, but its population-level impact depends on sufficient coverage. In 2023-2024, the Netherlands offered free HPV vaccination to individuals aged 19-27 years through a national catch-up campaign. For women, this was a second opportunity, as they had been offered vaccination at ages 9-13 through the National Immunisation Programme (NIP). Back then, uptake was relatively low (46-57% in these birth cohorts), but uptake increased to 55-63% following the catch-up vaccination. This campaign provided an apt opportunity to explore the factors underlying previous and current HPV vaccination decisions among the same women across two life stages. Methods: Between May 2023 and May 2024, 16 semi-structured interviews were conducted in Amsterdam with women who accepted HPV vaccination during the catch-up after non-uptake during early adolescence. Interviews explored factors influencing non-uptake and later acceptance, guided by the Health Belief Model and additional sociocultural constructs. Data were analysed using thematic analysis with open and theory-guided coding in MAXQDA. Results: Non-uptake during early adolescence was primarily shaped by parental decision-making, cultural and religious norms, fear of side effects, low perceived susceptibility to HPV and limited self-efficacy. Acceptance in young adulthood was driven by greater autonomy, higher perceived susceptibility, increased trust in accumulated vaccine evidence and accessible vaccination infrastructure. Peer influence replaced parental influence as the dominant social factor. Conclusion: HPV vaccine decision-making is a dynamic process rather than fixed. Permanent catch-up HPV vaccination opportunities would enable young adults to make autonomous vaccination decisions as their circumstances change.

medRxiv
Canterbury Christ Church University (GB), GGD Amsterdam (NL), Public Health Service of Amsterdam (NL), Amsterdam University Medical Centers (NL), University of Amsterdam (NL), Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
ZonMw
Good health and well-being
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon